Alcon (VTX:ALC) Second Quarter 2024 Results
Key Financial Results
- Revenue: US$2.50b (up 3.1% from 2Q 2023).
- Net income: US$223.0m (up 32% from 2Q 2023).
- Profit margin: 8.9% (up from 7.0% in 2Q 2023).
- EPS: US$0.45 (up from US$0.34 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Alcon Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 3.1%.
Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in Switzerland.
Performance of the Swiss Medical Equipment industry.
The company's share price is broadly unchanged from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Alcon's balance sheet.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SWX:ALC
Alcon
Researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.
Solid track record with adequate balance sheet.